Setrusumab
Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer[1].
Product Specifications
CAS Number
1847394-95-9
Product Name Alternative
BPS 804
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/setrusumab.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
[Setrusumab]
Molecular Weight
(143.44 kDa)
References & Citations
[1]Hesse E, et al. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness. JCI Insight. 2019 Apr 9;5 (9) :e125543.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1392377-01 0.05 mg (E-Coli)
Recombinant Kluyveromyces lactis Mating-type protein A2 (MATA2)
Sign In for Pricing
View Details MBS1392377-02 0.05 mg (Yeast)
Recombinant Kluyveromyces lactis Mating-type protein A2 (MATA2)
Sign In for Pricing
View Details MBS1392377-03 0.2 mg (E-Coli)
Recombinant Kluyveromyces lactis Mating-type protein A2 (MATA2)
Sign In for Pricing
View Details MBS1392377-04 0.05 mg (Baculovirus)
Recombinant Kluyveromyces lactis Mating-type protein A2 (MATA2)
Sign In for Pricing
View Details